The Sean M. Healey & AMG Center for ALS and Rapa Therapeutics Announce First Participant Enrolled in NIH-Sponsored ACT for ALS Expanded Access Protocol Evaluating Epigenetically Reprogrammed RAPA-501 Cell Therapy
The Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital and Rapa Therapeutics have announced the first participant enrolled in the Expanded Access to RAPA-501 Protocol (EAP